Sanofi Statistics
Share Statistics
Sanofi has 1.22B
shares outstanding. The number of shares has increased by -2.3%
in one year.
| Shares Outstanding | 1.22B |
| Shares Change (YoY) | -2.3% |
| Shares Change (QoQ) | -1.9% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 462.52K, so 0.04% of the outstanding
shares have been sold short.
| Short Interest | 462.52K |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.04% |
| Short Ratio (days to cover) | 52.23 |
Valuation Ratios
The PE ratio is 20.64 and the forward
PE ratio is 11.07.
Sanofi's PEG ratio is
5.92.
| PE Ratio | 20.64 |
| Forward PE | 11.07 |
| PS Ratio | 2.59 |
| Forward PS | 1.9 |
| PB Ratio | 1.48 |
| P/FCF Ratio | 19.49 |
| PEG Ratio | 5.92 |
Financial Ratio HistoryEnterprise Valuation
Sanofi has an Enterprise Value (EV) of 125.21B.
| EV / Sales | 2.83 |
| EV / EBITDA | 11.35 |
| EV / EBIT | 13.79 |
| EV / FCF | 21.27 |
Financial Position
The company has a current ratio of 1.46,
with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.46 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 3.04 |
| Interest Coverage | 9.68 |
Financial Efficiency
Return on Equity is 7.17% and Return on Invested Capital is 5.5%.
| Return on Equity | 7.17% |
| Return on Assets | 4.19% |
| Return on Invested Capital | 5.5% |
| Revenue Per Employee | $534,351.7 |
| Profits Per Employee | $67,086.56 |
| Employee Count | 82,878 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.4 |
Taxes
| Income Tax | 1.2B |
| Effective Tax Rate | 17.98% |
Stock Price Statistics
The stock price has increased by 3.71% in the
last 52 weeks. The beta is 0.43, so Sanofi's
price volatility has been higher than the market average.
| Beta | 0.43 |
| 52-Week Price Change | 3.71% |
| 50-Day Moving Average | 107.04 |
| 200-Day Moving Average | 105.81 |
| Relative Strength Index (RSI) | 48.12 |
| Average Volume (20 Days) | 6,753 |
Income Statement
In the last 12 months, Sanofi had revenue of 44.29B
and earned 5.56B
in profits. Earnings per share was 4.45.
| Revenue | 44.29B |
| Gross Profit | 31.08B |
| Operating Income | 7.25B |
| Net Income | 5.56B |
| EBITDA | 11.03B |
| EBIT | 7.45B |
| Earnings Per Share (EPS) | 4.45 |
Full Income StatementBalance Sheet
The company has 7.44B in cash and 17.91B in
debt, giving a net cash position of -10.46B.
| Cash & Cash Equivalents | 7.44B |
| Total Debt | 17.91B |
| Net Cash | -10.46B |
| Retained Earnings | n/a |
| Total Assets | 131.89B |
| Working Capital | 11.8B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 9.08B
and capital expenditures -3.19B, giving a free cash flow of 5.89B.
| Operating Cash Flow | 9.08B |
| Capital Expenditures | -3.19B |
| Free Cash Flow | 5.89B |
| FCF Per Share | 4.71 |
Full Cash Flow StatementMargins
Gross margin is 70.18%, with operating and profit margins of 16.38% and 12.55%.
| Gross Margin | 70.18% |
| Operating Margin | 16.38% |
| Pretax Margin | 15.12% |
| Profit Margin | 12.55% |
| EBITDA Margin | 24.91% |
| EBIT Margin | 16.38% |
| FCF Margin | 13.29% |
